antimicrobial resistance

R&D

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference

News

FDA clears new antibiotic for superbug infections

AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.

News

Dr Marc Gitzinger, chief executive of BioVersys

AMR biotech BioVersys plans to float on Swiss stock exchange

BioVersys has filed to list on the Swiss Stock Exchange, hoping to raise CHF80m for its novel antibacterial candidates.

R&D

Growing threat of AMR: UN calls for urgent global action

In response to the rise of AMR, world leaders recently convened at the United Nations General Assembly to forge a landmark commitment, setting ambitious targets and funding initiatives to c

News

FDA set to decide on GSK's gepotidacin antibiotic in March

The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics for uncomplicated urinary tract infections (uUTIs) in over 20 yea

News

HE Mia Mottley, prime minister of Barbados, who chairs the Global Leaders Group on AMR

World leaders seek 10% cut in antibiotic resistance deaths

In a landmark development, world leaders meeting at the United Nations officially adopted a political declaration on antimicrobial resistance (AMR), which includes a target of a 10% cut in

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

FDA clears new antibiotic for superbug infections

AMR biotech BioVersys plans to float on Swiss stock exchange

Growing threat of AMR: UN calls for urgent global action

FDA set to decide on GSK's gepotidacin antibiotic in March

World leaders seek 10% cut in antibiotic resistance deaths

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

antimicrobial resistance

Editor's Picks